Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries

Autores
Berrueta, Amanda Mabel; Hemingway Foday, Jennifer; Thorsten, Vanessa R.; Goldenberg, Robert L.; Carlo, Waldemar A.; Garces, Ana; Patel, Archana; Saleem, Sarah; Pasha, Omrana; Chomba, Elwyn; Hibberd, Patricia L.; Krebs, Nancy F.; Goudar, Shivaprasad; Derman, Richard J.; Esamai, Fabian; Liechty, Edward A.; Moore, Janet L.; McClure, Elizabeth M.; Koso Thomas, Marion; Buekens, Pierre; Belizan, Jose; Althabe, Fernando
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
BACKGROUND:Antenatal corticosteroids (ACS) for women at high risk of preterm birth is an effective intervention to reduce neonatal mortality among preterm babies delivered in hospital settings, but has not been widely used in low-middle resource settings. We sought to assess the rates of ACS use at all levels of health care in low and middle income countries (LMIC).METHODS:We assessed rates of ACS in 7 sites in 6 LMIC participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development´s Global Network for Women and Children´s Health Research Antenatal Corticosteroids Trial (ACT), a cluster-randomized trial to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of ACS. We conducted this analysis using data from the control clusters, which did not receive any components of the intervention and intended to follow usual care. We included women who delivered an infant with a birth weight <5th percentile, a proxy for preterm birth, and were enrolled in the Maternal Newborn Health (MNH) Registry between October 2011 and March 2014 in all clusters. A survey of the site investigators regarding existing policies on ACS in health facilities and for health workers in the community was part of pre-trial activities.RESULTS:Overall, of 51,523 women delivered in control clusters across all sites, the percentage of <5th percentile babies ranged from 3.5 % in Kenya to 10.7 % in Pakistan. There was variation among the sites in the use of ACS at all hospitals and among those hospitals having cesarean section and neonatal care capabilities (bag and mask and oxygen or mechanical ventilation). Rates of ACS use for <5th percentile babies in all hospitals ranged from 3.8 % in the Kenya sites to 44.5 % in the Argentina site, and in hospitals with cesarean section and neonatal care capabilities from 0 % in Zambia to 43.5 % in Argentina. ACS were rarely used in clinic or home deliveries at any site. Guidelines for ACS use at all levels of the health system were available for most of the sites.CONCLUSION:Our study reports an overall low utilization of ACS among mothers of <5th percentile infants in hospital and clinic deliveries in LMIC.
Fil: Berrueta, Amanda Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Hemingway Foday, Jennifer. University Of Durham; Reino Unido
Fil: Thorsten, Vanessa R.. University Of Durham; Reino Unido
Fil: Goldenberg, Robert L.. Columbia University; Estados Unidos
Fil: Carlo, Waldemar A.. University of Alabama at Birmingahm; Estados Unidos
Fil: Garces, Ana. Fundación para la Alimentación y Nutrición de Centro América y Panamá; Guatemala
Fil: Patel, Archana. Lata Medical Research Foundation, Indira Gandhi Government Medical College; India
Fil: Saleem, Sarah. Aga Khan University. Department of Community Health Sciences, ; Pakistán
Fil: Pasha, Omrana. Aga Khan University. Department of Community Health Sciences, ; Pakistán
Fil: Chomba, Elwyn. University Teaching Hospital; Zambia
Fil: Hibberd, Patricia L.. Massachusetts General Hospital; Estados Unidos
Fil: Krebs, Nancy F.. 0University of Colorado School of Medicine; Estados Unidos
Fil: Goudar, Shivaprasad. KLE University’s Jawaharlal Nehru Medical College,; India
Fil: Derman, Richard J.. 2Christiana Health Care; Estados Unidos
Fil: Esamai, Fabian. Moi University School of Medicine; Kenia
Fil: Liechty, Edward A.. Indiana University; Estados Unidos
Fil: Moore, Janet L.. University Of Durham; Reino Unido
Fil: McClure, Elizabeth M.. University Of Durham; Reino Unido
Fil: Koso Thomas, Marion. Eunice Kennedy Shriver National Institute of Child Health and Human Development; Estados Unidos
Fil: Buekens, Pierre. Tulane School of Public Health & Tropical Medicine; Estados Unidos
Fil: Belizan, Jose. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
Materia
Corticosteroids
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/48881

id CONICETDig_fc062d331f152d6d16b125174db331e0
oai_identifier_str oai:ri.conicet.gov.ar:11336/48881
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countriesBerrueta, Amanda MabelHemingway Foday, JenniferThorsten, Vanessa R.Goldenberg, Robert L.Carlo, Waldemar A.Garces, AnaPatel, ArchanaSaleem, SarahPasha, OmranaChomba, ElwynHibberd, Patricia L.Krebs, Nancy F.Goudar, ShivaprasadDerman, Richard J.Esamai, FabianLiechty, Edward A.Moore, Janet L.McClure, Elizabeth M.Koso Thomas, MarionBuekens, PierreBelizan, JoseAlthabe, FernandoCorticosteroidshttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3BACKGROUND:Antenatal corticosteroids (ACS) for women at high risk of preterm birth is an effective intervention to reduce neonatal mortality among preterm babies delivered in hospital settings, but has not been widely used in low-middle resource settings. We sought to assess the rates of ACS use at all levels of health care in low and middle income countries (LMIC).METHODS:We assessed rates of ACS in 7 sites in 6 LMIC participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development´s Global Network for Women and Children´s Health Research Antenatal Corticosteroids Trial (ACT), a cluster-randomized trial to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of ACS. We conducted this analysis using data from the control clusters, which did not receive any components of the intervention and intended to follow usual care. We included women who delivered an infant with a birth weight <5th percentile, a proxy for preterm birth, and were enrolled in the Maternal Newborn Health (MNH) Registry between October 2011 and March 2014 in all clusters. A survey of the site investigators regarding existing policies on ACS in health facilities and for health workers in the community was part of pre-trial activities.RESULTS:Overall, of 51,523 women delivered in control clusters across all sites, the percentage of <5th percentile babies ranged from 3.5 % in Kenya to 10.7 % in Pakistan. There was variation among the sites in the use of ACS at all hospitals and among those hospitals having cesarean section and neonatal care capabilities (bag and mask and oxygen or mechanical ventilation). Rates of ACS use for <5th percentile babies in all hospitals ranged from 3.8 % in the Kenya sites to 44.5 % in the Argentina site, and in hospitals with cesarean section and neonatal care capabilities from 0 % in Zambia to 43.5 % in Argentina. ACS were rarely used in clinic or home deliveries at any site. Guidelines for ACS use at all levels of the health system were available for most of the sites.CONCLUSION:Our study reports an overall low utilization of ACS among mothers of <5th percentile infants in hospital and clinic deliveries in LMIC.Fil: Berrueta, Amanda Mabel. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Hemingway Foday, Jennifer. University Of Durham; Reino UnidoFil: Thorsten, Vanessa R.. University Of Durham; Reino UnidoFil: Goldenberg, Robert L.. Columbia University; Estados UnidosFil: Carlo, Waldemar A.. University of Alabama at Birmingahm; Estados UnidosFil: Garces, Ana. Fundación para la Alimentación y Nutrición de Centro América y Panamá; GuatemalaFil: Patel, Archana. Lata Medical Research Foundation, Indira Gandhi Government Medical College; IndiaFil: Saleem, Sarah. Aga Khan University. Department of Community Health Sciences, ; PakistánFil: Pasha, Omrana. Aga Khan University. Department of Community Health Sciences, ; PakistánFil: Chomba, Elwyn. University Teaching Hospital; ZambiaFil: Hibberd, Patricia L.. Massachusetts General Hospital; Estados UnidosFil: Krebs, Nancy F.. 0University of Colorado School of Medicine; Estados UnidosFil: Goudar, Shivaprasad. KLE University’s Jawaharlal Nehru Medical College,; IndiaFil: Derman, Richard J.. 2Christiana Health Care; Estados UnidosFil: Esamai, Fabian. Moi University School of Medicine; KeniaFil: Liechty, Edward A.. Indiana University; Estados UnidosFil: Moore, Janet L.. University Of Durham; Reino UnidoFil: McClure, Elizabeth M.. University Of Durham; Reino UnidoFil: Koso Thomas, Marion. Eunice Kennedy Shriver National Institute of Child Health and Human Development; Estados UnidosFil: Buekens, Pierre. Tulane School of Public Health & Tropical Medicine; Estados UnidosFil: Belizan, Jose. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; ArgentinaBioMed Central2016-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/48881Berrueta, Amanda Mabel; Hemingway Foday, Jennifer; Thorsten, Vanessa R.; Goldenberg, Robert L.; Carlo, Waldemar A.; et al.; Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries; BioMed Central; Reproductive Health; 13; 1; 5-2016; 1-61471-2458CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/s12978-016-0176-2info:eu-repo/semantics/altIdentifier/url/https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-016-0176-2info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:02:57Zoai:ri.conicet.gov.ar:11336/48881instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:02:57.722CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
title Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
spellingShingle Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
Berrueta, Amanda Mabel
Corticosteroids
title_short Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
title_full Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
title_fullStr Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
title_full_unstemmed Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
title_sort Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries
dc.creator.none.fl_str_mv Berrueta, Amanda Mabel
Hemingway Foday, Jennifer
Thorsten, Vanessa R.
Goldenberg, Robert L.
Carlo, Waldemar A.
Garces, Ana
Patel, Archana
Saleem, Sarah
Pasha, Omrana
Chomba, Elwyn
Hibberd, Patricia L.
Krebs, Nancy F.
Goudar, Shivaprasad
Derman, Richard J.
Esamai, Fabian
Liechty, Edward A.
Moore, Janet L.
McClure, Elizabeth M.
Koso Thomas, Marion
Buekens, Pierre
Belizan, Jose
Althabe, Fernando
author Berrueta, Amanda Mabel
author_facet Berrueta, Amanda Mabel
Hemingway Foday, Jennifer
Thorsten, Vanessa R.
Goldenberg, Robert L.
Carlo, Waldemar A.
Garces, Ana
Patel, Archana
Saleem, Sarah
Pasha, Omrana
Chomba, Elwyn
Hibberd, Patricia L.
Krebs, Nancy F.
Goudar, Shivaprasad
Derman, Richard J.
Esamai, Fabian
Liechty, Edward A.
Moore, Janet L.
McClure, Elizabeth M.
Koso Thomas, Marion
Buekens, Pierre
Belizan, Jose
Althabe, Fernando
author_role author
author2 Hemingway Foday, Jennifer
Thorsten, Vanessa R.
Goldenberg, Robert L.
Carlo, Waldemar A.
Garces, Ana
Patel, Archana
Saleem, Sarah
Pasha, Omrana
Chomba, Elwyn
Hibberd, Patricia L.
Krebs, Nancy F.
Goudar, Shivaprasad
Derman, Richard J.
Esamai, Fabian
Liechty, Edward A.
Moore, Janet L.
McClure, Elizabeth M.
Koso Thomas, Marion
Buekens, Pierre
Belizan, Jose
Althabe, Fernando
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Corticosteroids
topic Corticosteroids
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv BACKGROUND:Antenatal corticosteroids (ACS) for women at high risk of preterm birth is an effective intervention to reduce neonatal mortality among preterm babies delivered in hospital settings, but has not been widely used in low-middle resource settings. We sought to assess the rates of ACS use at all levels of health care in low and middle income countries (LMIC).METHODS:We assessed rates of ACS in 7 sites in 6 LMIC participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development´s Global Network for Women and Children´s Health Research Antenatal Corticosteroids Trial (ACT), a cluster-randomized trial to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of ACS. We conducted this analysis using data from the control clusters, which did not receive any components of the intervention and intended to follow usual care. We included women who delivered an infant with a birth weight <5th percentile, a proxy for preterm birth, and were enrolled in the Maternal Newborn Health (MNH) Registry between October 2011 and March 2014 in all clusters. A survey of the site investigators regarding existing policies on ACS in health facilities and for health workers in the community was part of pre-trial activities.RESULTS:Overall, of 51,523 women delivered in control clusters across all sites, the percentage of <5th percentile babies ranged from 3.5 % in Kenya to 10.7 % in Pakistan. There was variation among the sites in the use of ACS at all hospitals and among those hospitals having cesarean section and neonatal care capabilities (bag and mask and oxygen or mechanical ventilation). Rates of ACS use for <5th percentile babies in all hospitals ranged from 3.8 % in the Kenya sites to 44.5 % in the Argentina site, and in hospitals with cesarean section and neonatal care capabilities from 0 % in Zambia to 43.5 % in Argentina. ACS were rarely used in clinic or home deliveries at any site. Guidelines for ACS use at all levels of the health system were available for most of the sites.CONCLUSION:Our study reports an overall low utilization of ACS among mothers of <5th percentile infants in hospital and clinic deliveries in LMIC.
Fil: Berrueta, Amanda Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Hemingway Foday, Jennifer. University Of Durham; Reino Unido
Fil: Thorsten, Vanessa R.. University Of Durham; Reino Unido
Fil: Goldenberg, Robert L.. Columbia University; Estados Unidos
Fil: Carlo, Waldemar A.. University of Alabama at Birmingahm; Estados Unidos
Fil: Garces, Ana. Fundación para la Alimentación y Nutrición de Centro América y Panamá; Guatemala
Fil: Patel, Archana. Lata Medical Research Foundation, Indira Gandhi Government Medical College; India
Fil: Saleem, Sarah. Aga Khan University. Department of Community Health Sciences, ; Pakistán
Fil: Pasha, Omrana. Aga Khan University. Department of Community Health Sciences, ; Pakistán
Fil: Chomba, Elwyn. University Teaching Hospital; Zambia
Fil: Hibberd, Patricia L.. Massachusetts General Hospital; Estados Unidos
Fil: Krebs, Nancy F.. 0University of Colorado School of Medicine; Estados Unidos
Fil: Goudar, Shivaprasad. KLE University’s Jawaharlal Nehru Medical College,; India
Fil: Derman, Richard J.. 2Christiana Health Care; Estados Unidos
Fil: Esamai, Fabian. Moi University School of Medicine; Kenia
Fil: Liechty, Edward A.. Indiana University; Estados Unidos
Fil: Moore, Janet L.. University Of Durham; Reino Unido
Fil: McClure, Elizabeth M.. University Of Durham; Reino Unido
Fil: Koso Thomas, Marion. Eunice Kennedy Shriver National Institute of Child Health and Human Development; Estados Unidos
Fil: Buekens, Pierre. Tulane School of Public Health & Tropical Medicine; Estados Unidos
Fil: Belizan, Jose. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Althabe, Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
description BACKGROUND:Antenatal corticosteroids (ACS) for women at high risk of preterm birth is an effective intervention to reduce neonatal mortality among preterm babies delivered in hospital settings, but has not been widely used in low-middle resource settings. We sought to assess the rates of ACS use at all levels of health care in low and middle income countries (LMIC).METHODS:We assessed rates of ACS in 7 sites in 6 LMIC participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development´s Global Network for Women and Children´s Health Research Antenatal Corticosteroids Trial (ACT), a cluster-randomized trial to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of ACS. We conducted this analysis using data from the control clusters, which did not receive any components of the intervention and intended to follow usual care. We included women who delivered an infant with a birth weight <5th percentile, a proxy for preterm birth, and were enrolled in the Maternal Newborn Health (MNH) Registry between October 2011 and March 2014 in all clusters. A survey of the site investigators regarding existing policies on ACS in health facilities and for health workers in the community was part of pre-trial activities.RESULTS:Overall, of 51,523 women delivered in control clusters across all sites, the percentage of <5th percentile babies ranged from 3.5 % in Kenya to 10.7 % in Pakistan. There was variation among the sites in the use of ACS at all hospitals and among those hospitals having cesarean section and neonatal care capabilities (bag and mask and oxygen or mechanical ventilation). Rates of ACS use for <5th percentile babies in all hospitals ranged from 3.8 % in the Kenya sites to 44.5 % in the Argentina site, and in hospitals with cesarean section and neonatal care capabilities from 0 % in Zambia to 43.5 % in Argentina. ACS were rarely used in clinic or home deliveries at any site. Guidelines for ACS use at all levels of the health system were available for most of the sites.CONCLUSION:Our study reports an overall low utilization of ACS among mothers of <5th percentile infants in hospital and clinic deliveries in LMIC.
publishDate 2016
dc.date.none.fl_str_mv 2016-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/48881
Berrueta, Amanda Mabel; Hemingway Foday, Jennifer; Thorsten, Vanessa R.; Goldenberg, Robert L.; Carlo, Waldemar A.; et al.; Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries; BioMed Central; Reproductive Health; 13; 1; 5-2016; 1-6
1471-2458
CONICET Digital
CONICET
url http://hdl.handle.net/11336/48881
identifier_str_mv Berrueta, Amanda Mabel; Hemingway Foday, Jennifer; Thorsten, Vanessa R.; Goldenberg, Robert L.; Carlo, Waldemar A.; et al.; Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries; BioMed Central; Reproductive Health; 13; 1; 5-2016; 1-6
1471-2458
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/s12978-016-0176-2
info:eu-repo/semantics/altIdentifier/url/https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-016-0176-2
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613839821209600
score 13.069144